Загрузка...
DopAmide: Novel, Water‐Soluble, Slow‐Release l‐dihydroxyphenylalanine (l‐DOPA) Precursor Moderates l‐DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons
BACKGROUND: Long‐term l‐dihydroxyphenylalanine (l‐DOPA) treatment of Parkinson's disease (PD) is associated with motor complications known as l‐DOPA‐induced dyskinesias (LID) and on/off fluctuations, which are linked to unsteady pulsatile dopaminergic stimulation. AIM: The objective of this stu...
Сохранить в:
| Опубликовано в: : | CNS Neurosci Ther |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492885/ https://ncbi.nlm.nih.gov/pubmed/26861609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12518 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|